MedPath

Individualized Perioperative Open-Lung Ventilatory Strategy During One-Lung Ventilation

Not Applicable
Conditions
Thoraric Surgery
Surgery Time Expected More Than Two Hours
Registration Number
NCT03182062
Lead Sponsor
Fundación para la Investigación del Hospital Clínico de Valencia
Brief Summary

The purpose of this study is to determine whether individualized ventilatory management during one-lung ventilation in patients scheduled for thoracic surgery, combining the use of low tidal volumes, alveolar recruitment maneuvers, individually titrated positive end-expiratory pressure and individually indicated ventilatory support will decrease postoperative pulmonary complications, ICU and hospital length of stay compared to a standardized Lung Protective Ventilation (LPV).

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1400
Inclusion Criteria
  • Planned thoracic surgery > 2 hours.
  • Signed informed consent for participation in the study.
Exclusion Criteria
  • Age less than 18 years.
  • Pregnant or breast-feeding.
  • Patients with BMI >35.
  • Syndrome of moderate or severe respiratory distress: PaO2/FiO2 < 200 mmHg.
  • Heart failure: NYHA IV.
  • Hemodynamic failure: CI <2.5 L/min/m2 and / or requirements before surgery ionotropic support.
  • Diagnosis or suspicion of intracranial hypertension (intracranial pressure> 15 mmHg).
  • Mechanical ventilation in the last 15 days.
  • Presence of pneumothorax. Presence of giant bullae on chest radiography or computed tomography (CT).
  • Patient with preoperatively CPAP.
  • Participation in another experimental protocol at the time of intervention selection.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Reduction of postoperative pulmonary complicationsUp to 7 postoperative days

composite of pulmonary infection, severe respiratory failure, acute respiratory distress syndrome, pneumothorax, bronchopleural fistula, atelectasis requiring bronchoscopy, empyema.

Secondary Outcome Measures
NameTimeMethod
Reduction of composite of postoperative complicationsUp to 7 and 30 postoperative days

Renal failure, cardiac failure, sepsis, septic shock, surgical site infection, urinary infection and other pulmonary complications not included in the primary outcome such as leaks, atelectasis, pleural effusion, empyema, dyspnea.

Reduction of composite of postoperative pulmonary complicationsUp to 30 postoperative days

suspicion of pulmonary infection, mild acute respiratory failure, severe respiratory failure, acute respiratory distress syndrome

Intensive care unit and hospital length of stay reduction1 year

Trial Locations

Locations (4)

Hospital Germans Trias i Pujol

🇪🇸

Badalona, Barcelona, Spain

Hospital de la Santa Creu i Sant Pau

🇪🇸

Barcelona, Spain

Hospital Gregorio Marañón

🇪🇸

Madrid, Spain

Hospital clínico universitario

🇪🇸

Valencia, Spain

Hospital Germans Trias i Pujol
🇪🇸Badalona, Barcelona, Spain
Jaume Canet, MD, PhD
Principal Investigator
© Copyright 2025. All Rights Reserved by MedPath